These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 436462)

  • 1. Influence of population screening on morbidity and mortality of cancer of the uterine cervix in Maribo Amt.
    Berget A
    Dan Med Bull; 1979 Apr; 26(2):91-100. PubMed ID: 436462
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for cervical neoplasia. A survey of the assumptions from studies on the screening in Maribo Amt.
    Berget A
    Dan Med Bull; 1979 Nov; 26(7):313-32. PubMed ID: 118850
    [No Abstract]   [Full Text] [Related]  

  • 3. [A comparison between mass screening for uterine neck cancer in the Districts of Frederiksberg and Maribo].
    Koch F; Klinken L; Albrechtsen R
    Nord Med; 1971 Dec; 86(50):1534. PubMed ID: 5135061
    [No Abstract]   [Full Text] [Related]  

  • 4. Population screening for cervical carcinoma in the Borough of Frederiksberg.
    Koch F; Stakemann G
    Acta Obstet Gynecol Scand; 1967; 46():Suppl 9:77-84. PubMed ID: 6075717
    [No Abstract]   [Full Text] [Related]  

  • 5. [Letter: Screening for uterine cancer].
    Horwitz O; Lysgaard-Hansen B; Grünfeld K
    Ugeskr Laeger; 1974 Sep; 136(40):2268-70. PubMed ID: 4410005
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cervix cancer screening can be cost-effective. Combination of vaginal smears and the HPV test should be even more beneficial].
    Bistoletti P; Ellström A; Dillner J; Sennfält K; Sparén P; Strander B
    Lakartidningen; 2005 Jun 13-26; 102(24-25):1874-6, 1878-9. PubMed ID: 16044766
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for uterine cancer in Iceland.
    Thorarinsson A; Jensson O; Bjarnason O
    Acta Cytol; 1969 May; 13(5):304-8. PubMed ID: 5256946
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problem of uterine and ovarian cancer mass screening].
    Ohmura M; Oda M
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1907-16. PubMed ID: 12465389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mortality from cancer of the uterine cervix in Denmark 1961-71].
    Grünfeld K; Horwitz O; Lysgaard-Hansen B
    Ugeskr Laeger; 1975 Jan; 137(5):251-9. PubMed ID: 1136032
    [No Abstract]   [Full Text] [Related]  

  • 10. Economics of screening for cancer of the cervix.
    Hicks S; Edwards D
    N Z Med J; 1986 Nov; 99(814):916. PubMed ID: 3468422
    [No Abstract]   [Full Text] [Related]  

  • 11. [Status of preventive screening for uterine cervix cancer in Denmark in 1994].
    Lynge E; Arffmann E; Erbs K; Hansen KC; Henriksen B; Holten IW; Hølund B; Jakobsen AB; Jespersen NB; Olesen F
    Ugeskr Laeger; 1994 Jan; 156(4):471-3. PubMed ID: 8140664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
    Cooper AL; Dornfeld-Finke JM; Banks HW; Davey DD; Modesitt SC
    Obstet Gynecol; 2006 Jan; 107(1):71-6. PubMed ID: 16394042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bleeding disorders. The cost of screening].
    Freilev LL
    Sygeplejersken; 1993 Jun; 93(26):17-8. PubMed ID: 8140520
    [No Abstract]   [Full Text] [Related]  

  • 14. [Costs and problems in cervix cancer screening are considerably underestimated].
    Bistoletti P
    Lakartidningen; 2000 Aug; 97(32-33):3506-8. PubMed ID: 11037597
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
    Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
    Jensen ML; Dybdahl H; Svanholm H
    Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Population screening for uterine cervix cancer: the negative effects of insufficient knowledge as to what is normal and abnormal].
    van der Graaf Y
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1569-71. PubMed ID: 12224477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The significance of organized screening for uterine cervix cancer in Denmark during 1968-1987].
    Lynge E; Engholm G; Madsen M
    Ugeskr Laeger; 1992 May; 154(19):1330-4. PubMed ID: 1598705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economics of screening for cervical cancer.
    Coldman AJ; Anderson GH
    N Z Med J; 1987 Jul; 100(827):425. PubMed ID: 3452069
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost effectiveness of population screening and rescreening for cervical cancer in the Netherlands.
    Boon ME; de Graaff Guilloud JC
    Acta Cytol; 1981; 25(5):539-42. PubMed ID: 6792845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.